I'm not sure if it was ever referred to in a press release or discussed in an interview with Leo Ehrlich. It's been bantered about on the boards. Quite frankly, I think that it's a horesrace in terms of who presents the data on Kevetrin at the upcoming conference. Will it be Dr Menon and the Cellceutix team, or will it be Dr. Shapiro and the team from Dana Farber. I feel certain that someone will present what might turn out to be mind numbing information regarding the next level in cancer treatment.